中国少妇大P毛茸茸

Company Profile Company News Core Team CSR
Annual Meeting 丨 Building the future......

Kunpeng Biological Annual Meeting 2019
January 03, 2020
Kunpeng Bio's 2019 annual conference has quietly kicked off
2019 is a year worth remembering
This year, every day of Kun Peng is changing and moving forward.
As the company continues to grow
Our team is also growing
Laughing on 2020, we strode
Build the future together, tomorrow will be more exciting!

未標題-1.jpg

未標題-1.jpg

未標題-1.jpg

未標題-1.jpg

未標題-1.jpg

未標題-1.jpg

未標題-1.jpg

未標題-1.jpg

未標題-1.jpg

In 2019, we irrigated harvest with sweat, made solid progress, made major breakthroughs in the development of core projects, established and improved the company's management team and system, the R & D team grew stronger, and the construction of the production base broke ground. The company transformed into a productive enterprise.
2020 is an important year for the company's development! We will complete the phase III clinical declaration of 3 major drugs; we will build our own production base! A major breakthrough in the development of blockbuster drugs such as "Insulin Degu" and "Somaglutide"!
Kun Peng spreads his wings for 90,000 miles, and fights in the sky without cliffs! We believe that with the hard work of all people and the leadership of the management of Kun Peng, the future of Kun Peng will be bright! The foundation will be evergreen! Kunpeng Biology will become China's "Novo Nordisk"!
Thank you all for your hard work in the past year! Thank you everyone for your help!
                                                                                                                                             --Chairman Message



 

中国少妇大P毛茸茸